ARTICLES OF INTEREST
TBRF ImmunoBlot
IgM and IgG
Now approved by New York State
Department of Health
PURPOSE
Borreliosis is caused by two groups of Borrelia:
B. burgdorferi group and the Tick-Borne Relapsing Fever (TBRF) Borrelia group. It was believed that B. burgdorferi group is the only group that causes Lyme-like symptoms.
Lyme ImmunoBlot
IgM and IgG
Now Approved by New York State
Department of Health
PURPOSE
Although IGeneX Lyme Western blot prepared from Borrelia burgdorferi (BB) strains B31 and 297 is one of the most sensitive test to detect B. burgdorferi specific antibodies in human serum, it does not detect antibodies to all the BB antigens.
Bartonella
Multi-Species Western Blot
IgM and IgG
PURPOSE
The Bartonella IgM and IgG Western Blots are designed to detect IgM and IgG antibodies to Bartonella species including Bartonella henselae, B. quintana, B. elizabethae and B. vinsonii antigens in serum of patients suspected of having Bartonella infection.
Broad Coverage
Ab Assay
Lyme and TBRF
PURPOSE
Borreliosis, a vector-borne disease caused by a bacterium-Borrelia: The Lyme Borreliae group and the Tick-Borne Relapsing Fever (TBRF) Borreliae group. The Lyme Borreliae group is transmitted by hard ticks (Ixodes)
and the TBRF Borreliae group is transmitted by hard (Ixodes) and soft (Ornithodorus) ticks.
The IGeneX Advantage
Test with confidence
For over 25 years, IGeneX has been at the forefront of diagnostic testing for Lyme disease and several other tick-borne diseases. In recent years, IGeneX has continued to lead the way on Borreliosis (Lyme and Tick-borne Relapsing Fever) testing through continued research and development from a dedicated team of tick-borne disease experts.
Lyme IgXSpot
PURPOSE
This test is recommended for detection of very early and/ or late detection of B. burgdorferi infection. For diagnostic purposes, the IgXSpot test results should be used in conjunction with clinical symptoms and other evidence available to the diagnosing physician.
CENAREM® 2020